Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Differential regulation of muscarinic M1 receptors by orthosteric and allosteric ligands.

Davis CN, Bradley SR, Schiffer HH, Friberg M, Koch K, Tolf BR, Bonhaus DW, Lameh J.

BMC Pharmacol. 2009 Dec 2;9:14. doi: 10.1186/1471-2210-9-14.

2.

Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist.

Vanover KE, Weiner DM, Makhay M, Veinbergs I, Gardell LR, Lameh J, Del Tredici AL, Piu F, Schiffer HH, Ott TR, Burstein ES, Uldam AK, Thygesen MB, Schlienger N, Andersson CM, Son TY, Harvey SC, Powell SB, Geyer MA, Tolf BR, Brann MR, Davis RE.

J Pharmacol Exp Ther. 2006 May;317(2):910-8. Epub 2006 Feb 9.

PMID:
16469866
3.

Pharmacological characterization of AC-90179 [2-(4-methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide hydrochloride]: a selective serotonin 2A receptor inverse agonist.

Vanover KE, Harvey SC, Son T, Bradley SR, Kold H, Makhay M, Veinbergs I, Spalding TA, Weiner DM, Andersson CM, Tolf BR, Brann MR, Hacksell U, Davis RE.

J Pharmacol Exp Ther. 2004 Sep;310(3):943-51. Epub 2004 Apr 21.

PMID:
15102927
4.

Synthesis and structure-activity relationships of new arylpiperazines: para substitution with electron-withdrawing groups decrease binding to 5-HT(1A) and D(2A) receptors.

Santana L, Uriarte E, Fall Y, Teijeira M, Terán C, García-Martínez E, Tolf BR.

Eur J Med Chem. 2002 Jun;37(6):503-10.

PMID:
12204476
5.

Anticonvulsant activity of a nonpeptide galanin receptor agonist.

Saar K, Mazarati AM, Mahlapuu R, Hallnemo G, Soomets U, Kilk K, Hellberg S, Pooga M, Tolf BR, Shi TS, Hökfelt T, Wasterlain C, Bartfai T, Langel U.

Proc Natl Acad Sci U S A. 2002 May 14;99(10):7136-41.

6.

Synthesis of novel 5-substituted 3-amino-3,4-dihydro-2H-1-benzopyran derivatives and their interactions with the 5-HT1A receptor.

Hammarberg E, Nordvall G, Leideborg R, Nylöf M, Hanson S, Johansson L, Thorberg SO, Tolf BR, Jerning E, Svantesson GT, Mohell N, Ahlgren C, Westlind-Danielsson A, Csöregh I, Johansson R.

J Med Chem. 2000 Jul 27;43(15):2837-50.

PMID:
10956192
7.

Phenylpiperazine derivatives with strong affinity for 5HT1A, D2A and D3 receptors.

Terán C, Santana L, Uriarte E, Fall Y, Unelius L, Tolf BR.

Bioorg Med Chem Lett. 1998 Dec 15;8(24):3567-70.

PMID:
9934472
8.

Munchausen-by-proxy syndrome: countertransference as a diagnostic tool.

Szajnberg NM, Moilanen I, Kanerva A, Tolf B.

Bull Menninger Clin. 1996 Spring;60(2):229-37.

PMID:
8857422
9.

Synthetic inhibitors of alcohol dehydrogenase. Pyrazoles containing polar groups directly attached to the pyrazole ring in the 4-position.

Tolf BR, Dahlbom R, Akeson A, Theorell H.

Acta Pharm Suec. 1985;22(3):147-56. No abstract available.

PMID:
2930995
10.

Synthetic inhibitors of alcohol dehydrogenase. Pyrazoles containing an unsaturated hydrocarbon residue in the 4-position.

Tolf BR, Dahlbom R, Theorell H, Akeson A.

Acta Chem Scand B. 1982;36(2):101-7.

PMID:
7044012
11.

Studies on the metabolic interactions between 4-methylpyrazole and methanol using the monkey as an animal model.

McMartin KE, Hedström KG, Tolf BR, Ostling-Wintzell H, Blomstrand R.

Arch Biochem Biophys. 1980 Feb;199(2):606-14. No abstract available.

PMID:
6767446
12.

Pyrazoles as inhibitors of alcohol oxidation and as important tools in alcohol research: an approach to therapy against methanol poisoning.

Blomstrand R, Ostling-Wintzell H, Löf A, McMartin K, Tolf BR, Hedström KG.

Proc Natl Acad Sci U S A. 1979 Jul;76(7):3499-503.

13.

On the inhibitory power of some further pyrazole derivatives of horse liver alcohol dehydrogenase.

Dahlbom R, Tolf BR, Akeson A, Lundquist G, Theorell H.

Biochem Biophys Res Commun. 1974 Apr 8;57(3):549-53. No abstract available.

PMID:
4827822

Supplemental Content

Support Center